Albert J. Uveges

797 total citations
11 papers, 658 citations indexed

About

Albert J. Uveges is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Albert J. Uveges has authored 11 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 3 papers in Pharmacology. Recurrent topics in Albert J. Uveges's work include Neuroscience and Neuropharmacology Research (3 papers), Receptor Mechanisms and Signaling (3 papers) and Neuropeptides and Animal Physiology (3 papers). Albert J. Uveges is often cited by papers focused on Neuroscience and Neuropharmacology Research (3 papers), Receptor Mechanisms and Signaling (3 papers) and Neuropeptides and Animal Physiology (3 papers). Albert J. Uveges collaborates with scholars based in United States and Canada. Albert J. Uveges's co-authors include Brian K. Kay, Dianne Kowal, Jeremy Kasanov, John M. Carter, Andrew B. Sparks, Stephen J. McConnell, Dana M. Fowlkes, Philip Jones, Garth T. Whiteside and Michael J. Piesla and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Analytical Biochemistry.

In The Last Decade

Albert J. Uveges

11 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Albert J. Uveges United States 9 401 198 187 76 72 11 658
Lucia Correa United States 17 523 1.3× 239 1.2× 165 0.9× 193 2.5× 66 0.9× 29 839
Chenggang Zhu China 10 274 0.7× 123 0.6× 176 0.9× 31 0.4× 32 0.4× 16 593
Aaron M. D’Antona United States 12 634 1.6× 441 2.2× 218 1.2× 29 0.4× 41 0.6× 25 892
Alan Chu China 8 300 0.7× 131 0.7× 121 0.6× 80 1.1× 37 0.5× 18 496
Lihua Wang‐Eckhardt Germany 10 243 0.6× 113 0.6× 221 1.2× 103 1.4× 64 0.9× 16 575
Corinne Schneider United States 12 333 0.8× 232 1.2× 85 0.5× 264 3.5× 117 1.6× 18 743
Edna Matta‐Camacho Canada 16 547 1.4× 215 1.1× 55 0.3× 39 0.5× 101 1.4× 21 869
Alison I. Muir United Kingdom 12 548 1.4× 383 1.9× 72 0.4× 340 4.5× 99 1.4× 14 1.3k
Michaela Müller Germany 13 522 1.3× 160 0.8× 30 0.2× 213 2.8× 58 0.8× 19 932

Countries citing papers authored by Albert J. Uveges

Since Specialization
Citations

This map shows the geographic impact of Albert J. Uveges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert J. Uveges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert J. Uveges more than expected).

Fields of papers citing papers by Albert J. Uveges

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert J. Uveges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert J. Uveges. The network helps show where Albert J. Uveges may publish in the future.

Co-authorship network of co-authors of Albert J. Uveges

This figure shows the co-authorship network connecting the top 25 collaborators of Albert J. Uveges. A scholar is included among the top collaborators of Albert J. Uveges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert J. Uveges. Albert J. Uveges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Flowers, Stephen, et al.. (2024). A novel TREX1 inhibitor, VB-85680, upregulates cellular interferon responses. PLoS ONE. 19(8). e0305962–e0305962. 3 indexed citations
2.
O’Neill, David J., Adedayo Adedoyin, Jenifer A. Bray, et al.. (2011). Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152). Journal of Medicinal Chemistry. 54(19). 6824–6831. 8 indexed citations
3.
Chanda, Pranab K., Ying Gao, Lilly Mark, et al.. (2010). Monoacylglycerol Lipase Activity Is a Critical Modulator of the Tone and Integrity of the Endocannabinoid System. Molecular Pharmacology. 78(6). 996–1003. 182 indexed citations
4.
O’Neill, David J., Adedayo Adedoyin, Peter D. Alfinito, et al.. (2010). Discovery of Novel Selective Norepinephrine Reuptake Inhibitors: 4-[3-Aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231). Journal of Medicinal Chemistry. 53(11). 4511–4521. 13 indexed citations
5.
Heinrich, Julia, John A. Butera, Angela Krämer, et al.. (2009). Pharmacological comparison of muscarinic ligands: Historical versus more recent muscarinic M1-preferring receptor agonists. European Journal of Pharmacology. 605(1-3). 53–56. 83 indexed citations
6.
Sullivan, Nicole R., Liza Leventhal, James Harrison, et al.. (2007). Pharmacological Characterization of the Muscarinic Agonist (3 R,4 R)-3-(3-Hexylsulfanyl-pyrazin-2-yloxy)-1-aza-bicyclo[2.2.1]heptane (WAY-132983) in in Vitro and in Vivo Models of Chronic Pain. Journal of Pharmacology and Experimental Therapeutics. 322(3). 1294–1304. 27 indexed citations
7.
Wang, Yuren, Jun Xu, Albert J. Uveges, et al.. (2006). A novel scintillation proximity assay for fatty acid amide hydrolase compatible with inhibitor screening. Analytical Biochemistry. 354(1). 35–42. 6 indexed citations
8.
Mahaney, Paige E., A. T. Vu, Casey C. McComas, et al.. (2006). Synthesis and activity of a new class of dual acting norepinephrine and serotonin reuptake inhibitors: 3-(1H-indol-1-yl)-3-arylpropan-1-amines. Bioorganic & Medicinal Chemistry. 14(24). 8455–8466. 30 indexed citations
9.
Uveges, Albert J., Dianne Kowal, Yingxin Zhang, et al.. (2002). The Role of Transmembrane Helix 5 in Agonist Binding to the Human H3 Receptor. Journal of Pharmacology and Experimental Therapeutics. 301(2). 451–458. 70 indexed citations
10.
Kasanov, Jeremy, et al.. (2001). Characterizing Class I WW domains defines key specificity determinants and generates mutant domains with novel specificities. Chemistry & Biology. 8(3). 231–241. 86 indexed citations
11.
McConnell, Stephen J., Albert J. Uveges, John M. Carter, et al.. (1997). Identification of Novel Human WW Domain-containing Proteins by Cloning of Ligand Targets. Journal of Biological Chemistry. 272(23). 14611–14616. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucia Correa Breakdown of academic impact, for papers by Chenggang Zhu Breakdown of academic impact, for papers by Aaron M. D’Antona Breakdown of academic impact, for papers by Alan Chu Breakdown of academic impact, for papers by Lihua Wang‐Eckhardt Breakdown of academic impact, for papers by Corinne Schneider Breakdown of academic impact, for papers by Edna Matta‐Camacho Breakdown of academic impact, for papers by Alison I. Muir Breakdown of academic impact, for papers by Michaela Müller
Rankless by CCL
2026